Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens

BACKGROUND: Taxane treatment may be a suitable therapeutic option for patients with castration‐resistant prostate cancer and high expression of constitutively active androgen receptor variants (AR‐Vs). The aim of the study was to compare the effects of cabazitaxel and androgen deprivation treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Ylitalo, Erik Bovinder, Thysell, Elin, Thellenberg‐Karlsson, Camilla, Lundholm, Marie, Widmark, Anders, Bergh, Anders, Josefsson, Andreas, Brattsand, Maria, Wikström, Pernilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973163/
https://www.ncbi.nlm.nih.gov/pubmed/31799745
http://dx.doi.org/10.1002/pros.23935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973163/
https://www.ncbi.nlm.nih.gov/pubmed/31799745
http://dx.doi.org/10.1002/pros.23935

Ejemplares similares